19920506
 Spreading Wealth: Pied Piper of Biotech Keeps Followers Happy with Cut-Rate Stock   By Cohen, Laurie P, The Wall Street Journal,  May 7, 1992  Investor David Blech, called the pied piper of biotechnology, is profiled. In little more than 10 years, Blech, head of brokerage firm D. Blech & Co, has amassed a fortune of about $310 million by starting biotechnology companies and financing distressed ones. Blech's unusual strategy of practically giving stock to brokers and influential Wall Streeters may account for his unusual success in biotechnology.   
